Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Share-based Compensation Share-based Compensation

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Outstanding Shares Outstanding

Autolus Therapeutics (AUTL) Shares Issued (2022 - 2024)

Autolus Therapeutics' Shares Issued history spans 3 years, with the latest figure at $550.0 million for Q1 2024.

For Q1 2024, Shares Issued changed N/A year-over-year to $550.0 million; the TTM value through Dec 2024 reached $550.0 million, changed N/A, while the annual FY2024 figure was $550.0 million, N/A changed from the prior year.
Shares Issued reached $550.0 million in Q1 2024 per AUTL's latest filing, up from -$4000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $550.0 million in Q1 2024 to a low of -$4000.0 in Q4 2023.
Average Shares Issued over 3 years is $178.4 million, with a median of $81.9 million recorded in 2022.
The largest YoY upside for Shares Issued was 100.0% in 2023 against a maximum downside of 100.0% in 2023.
A 3-year view of Shares Issued shows it stood at $163.7 million in 2022, then plummeted by 100.0% to -$4000.0 in 2023, then soared by 13749525.0% to $550.0 million in 2024.
Per Business Quant, the three most recent readings for AUTL's Shares Issued are $550.0 million (Q1 2024), -$4000.0 (Q4 2023), and $4000.0 (Q3 2023).